|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/57 | (2006.01) |
| A61K 38/57 | (2013.01) | ||
| A61P 37/06 | (2006.01) | ||
| A61P 37/06 | (2018.01) |
| (11) | Patento numeris | 3716998 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18821851.5 |
| Europos patento paraiškos padavimo data | 2018-11-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-10-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-01-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2018/063179 |
| Data | 2018-11-30 |
| (87) | Numeris | WO 2019/108865 |
| Data | 2019-06-06 |
| (30) | Numeris | Data | Šalis |
| 201762593446 P | 2017-12-01 | US | |
| 201862729376 P | 2018-09-10 | US |
| (72) |
UKNIS, Marc , US
VOIGT, Christine , US
BAHETI, Gautam , US
ROBERTS, John , US
|
| (73) |
CSL Behring LLC ,
1020 First Avenue, King of Prussia, PA 19406,
US
|
| (54) | A1AT FOR REDUCING RISK OF ONSET OF ACUTE GRAFT VERSUS HOST DISEASE AFTER HEMATOPOEITIC CELL TRANSPLANTATION |
| A1AT FOR REDUCING RISK OF ONSET OF ACUTE GRAFT VERSUS HOST DISEASE AFTER HEMATOPOEITIC CELL TRANSPLANTATION |